Qiagen N.V. (BIT:1QGEN)
Italy
· Delayed Price · Currency is EUR 40.47
+0.56 (1.39%)
At close: Dec 4, 2025
Qiagen Revenue
Qiagen had revenue of $532.58M USD in the quarter ending September 30, 2025, with 6.12% growth. This brings the company's revenue in the last twelve months to $2.07B, up 5.32% year-over-year. In the year 2024, Qiagen had annual revenue of $1.98B with 0.66% growth.
Revenue (ttm)
$2.07B
Revenue Growth
+5.32%
P/S Ratio
4.96
Revenue / Employee
$383.76K
Employees
5,396
Market Cap
8.76B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
| Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
| Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
| Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
| Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| DiaSorin | 1.21B |
| Amplifon | 2.41B |
| EL.En. | 580.41M |
| Philogen | 84.66M |
| Safilo Group | 998.89M |
| Pharmanutra | 127.15M |
| Garofalo Health Care | 483.61M |